You have 9 free searches left this month | for more free features.

Warfarin

Showing 1 - 25 of 1,186

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Left Ventricular Thrombus Trial in Peshawar (Warfarin, Rivaroxaban 20 MG Oral Tablet, Apixaban 5mg or 2.5mg oral tablet)

Recruiting
  • Left Ventricular Thrombus
  • Warfarin
  • +2 more
  • Peshawar, KPK, Pakistan
    Peshawar Institute of Cardiology
Jul 25, 2023

Drug Drug Interaction, Warfarin, Midazolam Trial in Guangzhou (ZSP1273)

Active, not recruiting
  • Drug Drug Interaction
  • +2 more
  • Guangzhou, China
    the Second Affiliated Hospital of Guangzhou Medical University
Jul 4, 2023

Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)

Not yet recruiting
  • Overweight Subjects
  • Obese Subjects
  • Beijing, Beijing, China
    Aerospace Center Hospital
Apr 4, 2023

Warfarin Trial in Hong Kong (Warfarin dosage adjustment model)

Recruiting
  • Warfarin
  • Warfarin dosage adjustment model
  • Hong Kong, Shatin, Hong Kong
    Prince of Wales Hospital
Nov 2, 2022

Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,

Not yet recruiting
  • Kawasaki Disease
  • +4 more
  • Rivaroxaban Oral Tablet or Suspension [Xarelto]
  • +2 more
  • (no location specified)
Dec 6, 2022

Atrial Fibrillation, Peritoneal Dialysis Complication Trial (Anticoagulation Agents)

Not yet recruiting
  • Atrial Fibrillation
  • Peritoneal Dialysis Complication
  • Anticoagulation Agents
  • (no location specified)
Sep 13, 2023

Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)

Not yet recruiting
  • Left Ventricular Thrombus
  • Myocardial Infarction
  • (no location specified)
Mar 31, 2023

Bleeding Post Cardiac Surgery, Indication for Anticoagulation Trial in Hamilton (DOAC, VKA)

Recruiting
  • Bleeding Post Cardiac Surgery
  • Indication for Anticoagulation
  • Hamilton, Ontario, Canada
    Hamilton General Hospital
Oct 31, 2022

CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )

Active, not recruiting
  • CTEPH
  • Fukuoka, Japan
    Kyushu University Hospital
Aug 30, 2022

Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction Trial in Tehran (Rivaroxaban 15 MG, Warfarin)

Recruiting
  • Left Ventricular Thrombus
  • ST Segment Elevation Myocardial Infarction
  • Rivaroxaban 15 MG
  • Warfarin
  • Tehran, Iran, Islamic Republic of
  • +1 more
Jan 21, 2023

Apixaban in Very Elderly Non-valvular Atrial Fibrillation

Recruiting
  • Non-valvular Atrial Fibrillation
  • Tokyo, Japan
    Pfizer Site
Aug 15, 2022

Liver Cirrhosis Trial (Caffeine, Warfarin sodium, Omeprazole)

Not yet recruiting
  • Liver Cirrhosis
  • (no location specified)
Feb 14, 2023

Hemophilia A, Hemophilia B, Blood Coagulation Disorders Trial in Seoul (TU7710, Normal saline)

Recruiting
  • Hemophilia A
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 8, 2023

Apixaban Compared to Warfarin in Secondary Prevention in Atrial

Completed
  • Non-valvular Atrial Fibrillation
  • Tokyo, Japan
    Pfizer
Sep 27, 2022

Atrial Fibrillation, Valvular Heart Disease Trial in Beijing (Gene-directed dosage of warfarin, standard dosage of warfarin)

Completed
  • Atrial Fibrillation
  • Valvular Heart Disease
  • Gene-directed dosage of warfarin
  • standard dosage of warfarin
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences Fuwai Hospital
Apr 28, 2022

Healthy Trial in Neu-Ulm (Midazolam, Warfarin, Daridorexant)

Not yet recruiting
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Aug 2, 2022

Anticoagulation, Coronary Endarterectomy Trial (Warfarin, DAPT, CE+CABG)

Not yet recruiting
  • Anticoagulation
  • Coronary Endarterectomy
  • Warfarin
  • +2 more
  • (no location specified)
Mar 26, 2023

Apixaban Compared to Warfarin in Non-valvular Atrial

Not yet recruiting
  • Non-valvular Atrial Fibrillation
    • (no location specified)
    Jul 20, 2022

    Kidney's Ability to Work Properly in Korean Non-valvular Atrial

    Active, not recruiting
    • Non-valvular Atrial Fibrillation (NVAF)
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Warfarin
    • Multiple Locations, Korea, Republic of
      Many locations
    Aug 11, 2022

    Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

    Recruiting
    • Cirrhosis
    • +3 more
    • Yangzhou, Jiangsu, China
      Clinical Medical College of Yangzhou University
    Mar 19, 2022

    Chronic Hepatitis B Trial (HRS5091 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)

    Completed
    • Chronic Hepatitis B
    • HRS5091 Tablets
    • +6 more
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Dec 22, 2022

    Clotting Disorder Trial (Reinforcement Learning, Heath Care Provider)

    Withdrawn
    • Clotting Disorder
    • Reinforcement Learning
    • Heath Care Provider
    • (no location specified)
    Feb 17, 2022

    Quality of Life Trial in Edmonton (Patient Self-Management)

    Completed
    • Quality of Life
    • Patient Self-Management
    • Edmonton, Alberta, Canada
      University of Alberta
    May 24, 2022

    Healthy Subjects Trial in Suzhou (Warfarin sodium tablets, Digoxin tablet, Probenecid tablets)

    Completed
    • Healthy Subjects
    • Warfarin sodium tablets
    • +3 more
    • Suzhou, China
      First Affiliated Hospital of Soochow University
    Mar 9, 2022

    Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)

    Not yet recruiting
    • Atopic Dermatitis
    • Caffeine
    • +6 more
    • (no location specified)
    May 26, 2023